Revolution Medicines (RVMD)
(Delayed Data from NSDQ)
$37.18 USD
+0.55 (1.50%)
Updated Aug 4, 2025 04:00 PM ET
After-Market: $37.18 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth F Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Revolution Medicines, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
RVMD 37.18 +0.55(1.50%)
Will RVMD be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for RVMD based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for RVMD
Wall Street Analysts Believe Revolution Medicines (RVMD) Could Rally 90.58%: Here's is How to Trade
Does Revolution Medicines (RVMD) Have the Potential to Rally 74.05% as Wall Street Analysts Expect?
RVMD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Keros Therapeutics (KROS) Soars 5.1%: Is Further Upside Left in the Stock?
Down -7.83% in 4 Weeks, Here's Why Revolution Medicines (RVMD) Looks Ripe for a Turnaround
Revolution Medicines (RVMD) Loses -7% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Other News for RVMD
Revolution Medicines Inc (RVMD) Announces Upcoming Q2 2025 Financial Results Release | RVMD ...
Revolution Medicines to Report Financial Results for Second Quarter 2025 After Market Close on ...
Revolution Medicines Inc (RVMD) Unveils Breakthrough in Targeted Cancer Therapy | RVMD stock news
Revolution Medicines (RVMD) Publishes Breakthrough on Zoldonrasib Targeting RAS G12D | RVMD ...
Revolution Medicines Announces Publication of a Peer-Reviewed Research Paper in Science on the ...